Archives

by in
Entry Author Date Location
Austin Biotech Mirna Therapeutics Nabs Nearly $42M in Series D Funding 04/30/15 Texas
Celladon Anticipates Layoffs After Its Gene Therapy Trial Fails 04/27/15 San Diego
West Coast Biotech Roundup: Juno, Genervon, Tekmira, DNANexus & More 04/23/15 Seattle
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Edge Brings in VC Backers, Gets $72.5M For Head Injury Drug 04/09/15 New York
Cancer Groups Tap The Crowd To Boost Clinical Trial Participation 04/01/15 Wisconsin
Austin’s Aeglea Biotherapeutics Raises $44M for Cancer Drug 03/23/15 Texas
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
With Data in Hand, Amicus Preps For Drug Filings in U.S., Europe 03/19/15 New York
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
Medical Adhesive Revolution Aims for a Better Wound-Sealing Therapy 03/12/15 Texas
Ocular’s Long-Lasting Eye Drug Tech Passes First Late-Stage Test 03/10/15 Boston
Houston Biotech Vapogenix Raises $5.1M for Skin-Numbing Drug 03/09/15 Texas
Focused on Glaucoma, Aerie Looks Toward Unblinding Critical Data 03/03/15 New York
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Fannin Spinout Acelerox Aims to Halt Immune Attacks With Nanotech 02/11/15 Texas
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
“21st Century Cures” By Year’s End? Its Backers Want More Ideas 02/09/15 National
With Early Data, Alkermes Plots Quick Jump to Pivotal Study For MS Drug 02/09/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
Dallas’ AveXis Gets $10M to Bring Gene Therapy to Rare Spinal Disorder 01/20/15 Texas
Qualcomm-Novartis Deal Portends Wave of Clinical Trial Innovation 01/15/15 San Diego
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Bluebird 4 For 4 As Gene Therapy Helps More Blood Disease Patients 12/08/14 Boston
At ASH, Sunesis Dices Data to Argue For “Failed” Leukemia Drug 12/07/14 San Francisco
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy 12/01/14 Boston
BioMarin Gambles $840M on Prosensa’s Duchenne Drug 11/24/14 San Francisco
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Page 1 of 13 next page »